Sue Yom is an Oncology physician affiliated with University of California, San Francisco. OpenAlex indexes 671 publications with 18,025 citations (h-index 59); ClinicalTrials.gov lists 11 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Radiation Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 Divisadero Street
H1031
San Francisco, CA 941431708
Telephone
415-353-7175Registry record last updated 8 Jul 2007.
Clinical trials
- Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Sponsor: University of California, San Francisco
- Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Sponsor: University of California, San Francisco
- Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
34%Blood Viscosity Reducer20.3%Pentoxifylline100%Part D<11 patientsAntiarrhythmic13.7%Lidocaine Hcl Viscous100%Part D≥12 patientsNervous system
29.4%Opioid Agonist11.1%Oxycodone Hcl100%Part D<11 patientsCholinergic Receptor Agonist9.2%Pilocarpine Hcl100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
15.7%Caries prophylactic agents15.7%Sodium Fluoride 5000 Plus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
University of California Los Angeles
FY2026$626,403R01CA269950 - XERO study: A Phase I study of CVGN8 for the treatment of Radiation-Induced Xerostomia
University of California, San Francisco
FY2026$525,127UG3DE036295 - Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients
University of California Los Angeles
FY2025$626,400R01CA269950
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025 - NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Journal of the National Comprehensive Cancer Network
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Owen Wolkowitz, MD
University of California, San Francisco
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”